CD30 (Ki-1) is a marker of lymphocyte activation and is characteristic of immunoblastic B cell or anaplastic T cell malignant lymphomas. CD30 is a member of the tumor necrosis factor receptor (TNF-R) superfamily. Expression of CD30 can also be seen in embryonal carcinomas, malignant melanomas, mesenchymal tumors, and activated T and B lymphocytes and plasma cells. Reed-Sternberg cells of classical Hodgkin lymphoma, as well as the neoplastic cells of anaplastic large cell lymphoma express CD30.
No special preparation is needed for CD 30 Count Immunohistochemistry Biopsy Tissue. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing CD 30 Count Immunohistochemistry Biopsy Tissue. Your doctor depending on your condition will give specific instructions.
|UNISEX||All age groups||A positive staining is seen in case of detection of conditions mentioned|